Fernando López-Redondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fernando López-Redondo has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Junko Kurokawa
Department of Bio-Informational Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka-shi, Shizuoka, 422-8526, Japan
3 shared publications Kazuyuki Nakajima
Department of Neurochemistry, National institute of Neuroscience, Kodaira, Tokyo, Japan
3 shared publicationsM.J. Alfaro
Departamento de Farmacologia, Facultad de Medicina, U. Complutense, 28040 Madrid, Spain [Tel. 34-1-3941220; Fax: 34-1-3941463
3 shared publicationsShinichi Kohsaka
3 shared publicationsAkira Hasegawa
Laboratory for Large-Scale Biomedical Data Technology, RIKEN Center for Integrative Medical Sciences
2 shared publications- Carlos Goicoechea
Department of Basic Health Sciences, Universidad Rey Juan Carlos, 28922 Madrid, Spain
2 shared publications
Latest Publications
- Open Access
A single-cell atlas of transcribed cis -regulatory elements in the human genome
Summary: Transcribed cis-regulatory elements (tCREs), such as promoters and enhancers, are fundamental to modulate gene expression and define cell identity. The detailed mapping of tCREs at single-cell resolution is essential for understanding the regulatory mechanisms that govern cellular functions. Prior tCRE catalogs, limited by bulk analysis, have often overlooked cellular heterogeneity. We have constructed a tCRE atlas using single-cell 5’-RNA-seq, capturing over 340,000 single-cells from 23 human tissues and annotating more than 175,000 tCREs, substantially enhancing the scope and granularity of existing cis -regulatory element annotations in the human genome. This atlas unveils patterns of gene regulation, revealing connections between broadly expressed promoters and cell type-specific distal tCREs. Assessing trait heritability at single-cell resolution with a novel tCRE module-based approach, we uncovered the nuanced trait-gene regulatory relationships across a continuum of cell populations, offering insights beyond traditional gene-level and bulk-sample analyses. Our study bridges the gap between gene regulation and trait heritability, underscoring the potential of single-cell analysis to elucidate the genetic foundations of complex traits. These insights set the stage for future research to investigate the impact of genetic variations on diseases at the individual level, advancing the understanding of cellular and molecular basis of trait heritability.
Open AccessA single-cell atlas of transcribed cis -regulatory elements in the human genome
Summary: Transcribed cis-regulatory elements (tCREs), such as promoters and enhancers, are fundamental to modulate gene expression and define cell identity. The detailed mapping of tCREs at single-cell resolution is essential for understanding the regulatory mechanisms that govern cellular functions. Prior tCRE catalogs, limited by bulk analysis, have often overlooked cellular heterogeneity. We have constructed a tCRE atlas using single-cell 5’-RNA-seq, capturing over 340,000 single-cells from 23 human tissues and annotating more than 175,000 tCREs, substantially enhancing the scope and granularity of existing cis -regulatory element annotations in the human genome. This atlas unveils patterns of gene regulation, revealing connections between broadly expressed promoters and cell type-specific distal tCREs. Assessing trait heritability at single-cell resolution with a novel tCRE module-based approach, we uncovered the nuanced trait-gene regulatory relationships across a continuum of cell populations, offering insights beyond traditional gene-level and bulk-sample analyses. Our study bridges the gap between gene regulation and trait heritability, underscoring the potential of single-cell analysis to elucidate the genetic foundations of complex traits. These insights set the stage for future research to investigate the impact of genetic variations on diseases at the individual level, advancing the understanding of cellular and molecular basis of trait heritability.
- Open Access
Antisense oligonucleotide-mediated perturbation of long non-coding RNA reveals functional features in stem cells and across cell types
Summary: Within the scope of FANTOM6 consortium, we perform a large-scale knockdown of 200 long non-coding RNAs (lncRNAs) in human induced pluripotent stem (iPS) cells, and systematically characterize their roles in self-renewal and pluripotency. We find 36 lncRNAs (18%) exhibiting cell growth inhibition From the knockdown of 123 lncRNAs with transcriptome profiling, 36 lncRNAs (29.3%) show molecular phenotypes. Integrating the molecular phenotypes with chromatin-interaction assays further reveals cis - and trans -interacting partners as potential primary targets. Additionally, cell type enrichment analysis identifies lncRNAs associated with pluripotency while the knockdown of LINC02595 , CATG00000090305.1 and RP11-148B6.2 modulates colony formation of iPS cells. We compare our results with previously published fibroblasts phenotyping data and find that 2.9% of the lncRNAs exhibit consistent cell growth phenotype, whereas we observe 58.3% agreement in molecular phenotypes. This highlights molecular phenotyping is more comprehensive in revealing affected pathways.
Open AccessAntisense oligonucleotide-mediated perturbation of long non-coding RNA reveals functional features in stem cells and across cell types
Summary: Within the scope of FANTOM6 consortium, we perform a large-scale knockdown of 200 long non-coding RNAs (lncRNAs) in human induced pluripotent stem (iPS) cells, and systematically characterize their roles in self-renewal and pluripotency. We find 36 lncRNAs (18%) exhibiting cell growth inhibition From the knockdown of 123 lncRNAs with transcriptome profiling, 36 lncRNAs (29.3%) show molecular phenotypes. Integrating the molecular phenotypes with chromatin-interaction assays further reveals cis - and trans -interacting partners as potential primary targets. Additionally, cell type enrichment analysis identifies lncRNAs associated with pluripotency while the knockdown of LINC02595 , CATG00000090305.1 and RP11-148B6.2 modulates colony formation of iPS cells. We compare our results with previously published fibroblasts phenotyping data and find that 2.9% of the lncRNAs exhibit consistent cell growth phenotype, whereas we observe 58.3% agreement in molecular phenotypes. This highlights molecular phenotyping is more comprehensive in revealing affected pathways.
- Open Access
- 14 June 2017
- Published by Wiley in The Journal of Physiology
- Vol. 595 (14) , 4695-4723
A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal‐induced arrhythmias
Key points: This study represents a first step toward predicting mechanisms of sex‐based arrhythmias that may lead to important developments in risk stratification and may inform future drug design and screening. We undertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation) required for triggering and sustaining reentrant arrhythmias. Using the recently solved cryo‐EM structure for the Eag‐family channel as a template, we revealed potential interactions of oestrogen with the pore loop hERG mutation (G604S). Molecular models suggest that oestrogen and dofetilide blockade can concur simultaneously in the hERG channel pore. Female sex is a risk factor for inherited and acquired long‐QT associated torsade de pointes (TdP) arrhythmias, and sympathetic discharge is a major factor in triggering TdP in female long‐QT syndrome patients. We used a combined experimental and computational approach to predict ‘the perfect storm’ of hormone concentration,IKrblock and sympathetic stimulation that induces arrhythmia in females with inherited and acquired long‐QT. More specifically, we developed mathematical models of acquired and inherited long‐QT syndrome in male and female ventricular human myocytes by combining effects of a hormone and a hERG blocker, dofetilide, or hERG mutations. These ‘male’ and ‘female’ model myocytes and tissues then were used to predict how various sex‐based differences underlie arrhythmia risk in the setting of acute sympathetic nervous system discharge. The model predicted increased risk for arrhythmia in females when acute sympathetic nervous system discharge was applied in the settings of both inherited and acquired long‐QT syndrome. Females were predicted to have protection from arrhythmia induction when progesterone is high. Males were protected by the presence of testosterone. Structural modelling points towards two plausible and distinct mechanisms of oestrogen action enhancing torsadogenic effects: oestradiol interaction with hERG mutations in the pore loop containing G604 or with common TdP‐related blockers in the intra‐cavity binding site. Our study presents findings that constitute the first evidence linking structure to function mechanisms underlying female dominance of arousal‐induced arrhythmias.
- 14 June 2017
- Published by Wiley in The Journal of Physiology
- Vol. 595 (14) , 4695-4723
Open AccessA multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal‐induced arrhythmias
Key points: This study represents a first step toward predicting mechanisms of sex‐based arrhythmias that may lead to important developments in risk stratification and may inform future drug design and screening. We undertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation) required for triggering and sustaining reentrant arrhythmias. Using the recently solved cryo‐EM structure for the Eag‐family channel as a template, we revealed potential interactions of oestrogen with the pore loop hERG mutation (G604S). Molecular models suggest that oestrogen and dofetilide blockade can concur simultaneously in the hERG channel pore. Female sex is a risk factor for inherited and acquired long‐QT associated torsade de pointes (TdP) arrhythmias, and sympathetic discharge is a major factor in triggering TdP in female long‐QT syndrome patients. We used a combined experimental and computational approach to predict ‘the perfect storm’ of hormone concentration,IKrblock and sympathetic stimulation that induces arrhythmia in females with inherited and acquired long‐QT. More specifically, we developed mathematical models of acquired and inherited long‐QT syndrome in male and female ventricular human myocytes by combining effects of a hormone and a hERG blocker, dofetilide, or hERG mutations. These ‘male’ and ‘female’ model myocytes and tissues then were used to predict how various sex‐based differences underlie arrhythmia risk in the setting of acute sympathetic nervous system discharge. The model predicted increased risk for arrhythmia in females when acute sympathetic nervous system discharge was applied in the settings of both inherited and acquired long‐QT syndrome. Females were predicted to have protection from arrhythmia induction when progesterone is high. Males were protected by the presence of testosterone. Structural modelling points towards two plausible and distinct mechanisms of oestrogen action enhancing torsadogenic effects: oestradiol interaction with hERG mutations in the pore loop containing G604 or with common TdP‐related blockers in the intra‐cavity binding site. Our study presents findings that constitute the first evidence linking structure to function mechanisms underlying female dominance of arousal‐induced arrhythmias.
- Open Access
- 1 June 2016
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 131 (2) , 141-145
A distribution analysis of action potential parameters obtained from patch-clamped human stem cell-derived cardiomyocytes
- 1 June 2016
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 131 (2) , 141-145
Open AccessA distribution analysis of action potential parameters obtained from patch-clamped human stem cell-derived cardiomyocytes
- 1 January 2013
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 53 (supplement) , S247
3P216 A comparative study on electrophysiological properties of human iPS- and ES-derived cardiomyocytes(13C. Biological & Artifical membrane: Excitation & Channels,Poster)
- 1 January 2013
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 53 (supplement) , S247
3P216 A comparative study on electrophysiological properties of human iPS- and ES-derived cardiomyocytes(13C. Biological & Artifical membrane: Excitation & Channels,Poster)
- 1 June 2001
- Published by Elsevier in Biomaterials
- Vol. 22 (11) , 1213-1223
Intact microglia are cultured and non-invasively harvested without pathological activation using a novel cultured cell recovery method
- 1 June 2001
- Published by Elsevier in Biomaterials
- Vol. 22 (11) , 1213-1223
Intact microglia are cultured and non-invasively harvested without pathological activation using a novel cultured cell recovery method
- 1 March 2000
- Published by Elsevier in Molecular Brain Research
- Vol. 76 (2) , 429-435
Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy
- 1 March 2000
- Published by Elsevier in Molecular Brain Research
- Vol. 76 (2) , 429-435
Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy
- 1 December 1998
- Published by Elsevier in Brain Research
- Vol. 813 (2) , 241-253
The microglia/macrophage response in the neonatal rat facial nucleus following axotomy
- 1 December 1998
- Published by Elsevier in Brain Research
- Vol. 813 (2) , 241-253
The microglia/macrophage response in the neonatal rat facial nucleus following axotomy
- 1 September 1997
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (2) , 330-334
Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea‐pig ileum
The effect of cannabinoid receptor agonists was studied in guinea‐pig myenteric neurones in vitro by use of conventional intracellular recording techniques. Exposure of myenteric neurones of the S‐cell type to the cannabinoid receptor agonists WIN 55,212‐2 (100 nM) and CP 55,940 (100 nM) reversibly and significantly depressed the amplitude of fast excitatory synaptic potentials (fast e.p.s.ps) by 46% and 37%, respectively. The depressant effect of WIN 55,212‐2 and CP 55,940 on fast e.p.s.p. amplitude (expressed as the area above the amplitude‐time curve (mVs)) was significantly greater than that of the vehicle, Tween 80, which had no detectable effect. The inhibitory effect of WIN 55,212‐2 appeared to be concentration‐dependent over the range 1–100 nM. WIN 55,212‐3, its (−)‐enantiomer (100 nM), was inactive. The cannabinoid CB1 receptor antagonist, SR141716A (1 μM), reversed the inhibitory effects of WIN 55,212‐2 on fast e.p.s.ps in 38% of neurones tested (3/8) and acetylcholine (ACh)‐induced depolarizations in 42% of neurones tested (5/12). When tested on its own, SR141716A (1 μM) caused a 40–50% reduction in the amplitude of fast e.p.s.ps (n=9). WIN 55,212‐2 reversibly depressed the amplitude of the slow e.p.s.p. and, in 2 out of 7 neurones, this effect was reversed by SR141716A (1 μM). It is concluded that cannabinoid‐induced inhibition of fast cholinergic synaptic transmission occurred by reversible activation of both presynaptic and postsynaptic CB1 receptors and that slow excitatory synaptic transmission can also be reversibly depressed by cannabinoids. Furthermore, it would seem that subpopulations of myenteric S‐neurones and their synapsing cholinergic and non‐cholinergic, non‐adrenergic terminals are not endowed with cannabinoid receptors. British Journal of Pharmacology (1997) 122, 330–334; doi:10.1038/sj.bjp.0701393
- 1 September 1997
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (2) , 330-334
Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea‐pig ileum
The effect of cannabinoid receptor agonists was studied in guinea‐pig myenteric neurones in vitro by use of conventional intracellular recording techniques. Exposure of myenteric neurones of the S‐cell type to the cannabinoid receptor agonists WIN 55,212‐2 (100 nM) and CP 55,940 (100 nM) reversibly and significantly depressed the amplitude of fast excitatory synaptic potentials (fast e.p.s.ps) by 46% and 37%, respectively. The depressant effect of WIN 55,212‐2 and CP 55,940 on fast e.p.s.p. amplitude (expressed as the area above the amplitude‐time curve (mVs)) was significantly greater than that of the vehicle, Tween 80, which had no detectable effect. The inhibitory effect of WIN 55,212‐2 appeared to be concentration‐dependent over the range 1–100 nM. WIN 55,212‐3, its (−)‐enantiomer (100 nM), was inactive. The cannabinoid CB1 receptor antagonist, SR141716A (1 μM), reversed the inhibitory effects of WIN 55,212‐2 on fast e.p.s.ps in 38% of neurones tested (3/8) and acetylcholine (ACh)‐induced depolarizations in 42% of neurones tested (5/12). When tested on its own, SR141716A (1 μM) caused a 40–50% reduction in the amplitude of fast e.p.s.ps (n=9). WIN 55,212‐2 reversibly depressed the amplitude of the slow e.p.s.p. and, in 2 out of 7 neurones, this effect was reversed by SR141716A (1 μM). It is concluded that cannabinoid‐induced inhibition of fast cholinergic synaptic transmission occurred by reversible activation of both presynaptic and postsynaptic CB1 receptors and that slow excitatory synaptic transmission can also be reversibly depressed by cannabinoids. Furthermore, it would seem that subpopulations of myenteric S‐neurones and their synapsing cholinergic and non‐cholinergic, non‐adrenergic terminals are not endowed with cannabinoid receptors. British Journal of Pharmacology (1997) 122, 330–334; doi:10.1038/sj.bjp.0701393
- 1 May 1995
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (3) , 641-647
Analgesic effect of two calcitonins and in vitro interaction with opioids
- 1 May 1995
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (3) , 641-647
Analgesic effect of two calcitonins and in vitro interaction with opioids